Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy

被引:0
|
作者
Liang, Ze-Yu [1 ]
Wang, Yi-Peng [2 ]
Li, Jing [1 ]
Yang, Wen-Chao [2 ]
Tu, Yong-Fang [2 ]
Zhang, Yue [1 ]
Chen, Song [1 ]
机构
[1] Nankai Univ, Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci,Affiliated, Tianjin 300020, Peoples R China
[2] Anyang Eye Hosp, Anyang 455000, Henan, Peoples R China
关键词
  proliferative diabetic retinopathy; ranibizumab; fibrovascular membranes; glial-mesenchymal transition; microvessel density; ENDOTHELIAL-CELLS; MULLER GLIA; BEVACIZUMAB; EXPRESSION; MARKER; VEGF;
D O I
10.18240/ijo.2022.10.03
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
? AIM: To assess the effects of intravitreal ranibizumab (IVR) on angiogenesis and glial activity of the fibrovascular membrane (FVM) in patients with proliferative diabetic retinopathy (PDR).? METHODS: Forty-two eyes from 42 patients with PDR requiring vitrectomy were included and divided into two groups: control group (n=16) did not receive IVR, while IVR group (n=26) underwent IVR 5d before vitrectomy. FVM specimens were collected by the same surgeon during the interventions. Histopathological morphology was examined by hematoxylin-eosin (H-E) staining and cell densities in the FVM was assessed. Microvessels were outlined by immunohistochemical staining of CD31 and microvessel density (MVD) assessed as an index of FVM angiogenesis. Dual-color immunofluorescence staining, and confocal microscopy was used to detect co-localization and relative expression levels of glial fibrillary acidic protein (GFAP) and alpha-smooth muscle actin (alpha-SMA) as markers of glial-mesenchymal transition (GMT). The GMT index (GI; ratio of relative GFAP/alpha-SMA expression) was used to semi-quantify the degree of GMT or glial activity of FVMs.? RESULTS: H-E staining showed similar vascularization in both groups, with microvessels and scattered stromal cells in the matrix. Infiltrated cell densities did not differ significantly between the two groups (P>0.05). The MVD of the IVR group (130.62 +/- 15.46/mm2) was significantly lower than that of the controls (142.25 +/- 19.16/mm2, P<0.05). In both groups, all sections were strongly immunostained for GFAP and alpha-SMA. The Pearson's correlation coefficients (PCC) of intensity of automated pixel count of two markers indicated GFAP and alpha-SMA co-stained well and GMT participated in the remolding of FVMs in PDR. The mean relative GFAP expression in the IVR group was significantly lower, whereas that of alpha-SMA was significantly higher than in controls (P<0.05). GI in the IVR group (1.10 +/- 0.10) was significantly lower than in the controls (1.21 +/- 0.12, P<0.05).? CONCLUSION: IVR can reduce angiogenesis, glial activity of FVM and promote glial-fibrotic transformation by reducing MVD and promoting GMT but does not decrease the cell density in patients with PDR.
引用
收藏
页码:1577 / 1585
页数:9
相关论文
共 50 条
  • [1] Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy
    Ze-Yu Liang
    Yi-Peng Wang
    Jing Li
    Wen-Chao Yang
    Yong-Fang Tu
    Yue Zhang
    Song Chen
    International Journal of Ophthalmology, 2022, 15 (10) : 1577 - 1585
  • [2] HISTOLOGY OF FIBROVASCULAR MEMBRANES OF PROLIFERATIVE DIABETIC RETINOPATHY AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB
    Kubota, Toshiaki
    Morita, Hirofumi
    Tou, Norihiko
    Nitta, Norikazu
    Tawara, Akihiko
    Satoh, Hitoshi
    Shimajiri, Shohei
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (03): : 468 - 472
  • [3] Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy
    Chen, Hui-Jin
    Wang, Chang-Guan
    Dou, Hong-Liang
    Feng, Xue-Feng
    Xu, Yi-Min
    Ma, Zhi-Zhong
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (01) : 82 - 89
  • [4] The effect and safety of intravitreal ranibizumab combined with vitrectomy for proliferative diabetic retinopathy
    Rong, Hua
    Xu, Yueli
    Zhang, Meiping
    Cai, Minyun
    Cui, Hongping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04): : 7163 - 7167
  • [5] Intravitreal ranibizumab for Vitreous hemorrhage in Proliferative Diabetic Retinopathy
    Dirani, Ali
    Fadlallah, Ali
    Azar, George
    Chelala, Elias
    Nehme, Joseph
    Alameddine, Ramzi
    Jalkh, Alexandre
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [6] Sequence effect in the treatment of proliferative diabetic retinopathy with intravitreal ranibizumab and panretinal photocoagulation
    Cao, Guofan
    Xu, Xiangzhong
    Wang, Chenghu
    Zhang, Shu
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (01) : 34 - 39
  • [7] Gene expression profile of fibrovascular membranes from patients with proliferative diabetic retinopathy
    Yoshida, Shigeo
    Ogura, Atsushi
    Ishikawa, Keijiro
    Yoshida, Ayako
    Kohno, Richiro
    Yamaji, Yoko
    Ikeo, Kazuho
    Gojobori, Takashi
    Kono, Toshihiro
    Ishibashi, Tatsuro
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (06) : 795 - 801
  • [8] Apelin in Plasma and Vitreous and in Fibrovascular Retinal Membranes of Patients with Proliferative Diabetic Retinopathy
    Tao, Yong
    Lu, Qiang
    Jiang, Yan-Rong
    Qian, Jing
    Wang, Jia-Yan
    Gao, Lei
    Jonas, Jost B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (08) : 4237 - 4242
  • [9] Angiofibrotic Response to Bevacizumab on Fibrovascular Membranes in Proliferative Diabetic Retinopathy
    Jiao, Chunhua
    Spee, Christine
    He, Shikun
    Mullins, Robert
    Eliott, Dean
    Hinton, David R.
    Sohn, Elliott H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [10] Expressed Sequence Tag Analysis of Fibrovascular Membranes from Patients with Proliferative Diabetic Retinopathy
    Yoshida, S.
    Ogura, A.
    Ishikawa, K.
    Kohno, R.
    Ikeo, K.
    Gojobori, T.
    Kono, T.
    Ishibashi, T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)